Q2 order intake rose 29% to SEK 22,235m (vs. SEK 16,444m), driven by a 29% organic increase. Net sales increased 6% to SEK 18,100m (from SEK 16,800m) and adjusted EBITA edged up 2% to SEK 3.1bn, but EBITA margin declined to 17.0% from 17.8%. Operating cash flow was SEK 2.4bn (vs. SEK 2.2bn) and EPS rose slightly to SEK 4.91 (from SEK 4.87).
The key signal is not demand strength — it is that demand is translating into weaker incremental economics. In industrials, that usually means one of three things: mix is drifting toward lower-margin projects, pricing is lagging input/labor inflation, or the company is booking backlog faster than it can execute efficiently. That is usually bullish for revenue visibility but only modestly bullish for earnings, so the market should be more selective than the headline order beat suggests.
Second-order winners are the higher-quality peers with more service/aftermarket exposure and better pricing discipline, such as Atlas Copco, Sandvik, or SKF, because they can capture the same industrial recovery without sacrificing margin. Losers are lower-quality project-exposed suppliers and subcontractors that compete on volume and may face a backlog of low-return work if this firm is bidding aggressively to defend share. If the order spike reflects front-loading ahead of macro or tariff uncertainty, that can create a false peak in demand and set up a softer 1-3 month comparison.
The main falsifier is cash conversion and margin trajectory over the next two quarters: if operating cash flow stays firm while EBITA margin stabilizes, the market can re-rate this as a healthy backlog-to-sales transition. If margin falls again despite high order growth, then this is no longer a growth story but a quality-of-earnings problem, and multiples should compress. The next catalyst is guidance wording around pricing, mix, and cancellation rates; those will matter more than the order number itself.
Contrarian view: the consensus may be too quick to punish the margin dip. In cyclical industrials, strong orders often precede margin recovery with a lag, and the current print could be an early-stage utilization benefit rather than structural deterioration. But without evidence of pricing power, the upside is limited; this is a name to monitor, not to chase aggressively on day one.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.18